Morley, N J <br/><br/>
Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia.  [electronic resource] 

 -  Expert review of anticancer therapy  2016 
 - 159-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8328 
<br/><br/><label>Standard No.: </label>10.1586/14737140.2016.1131614  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Apoptosis--drug effects<br/>Humans<br/>Inotuzumab Ozogamicin<br/>Molecular Targeted Therapy<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Recurrence